S S Casagrande1, A Menke1, B Linder2, S K Osganian2, C C Cowie2. 1. Social & Scientific Systems, Inc., Silver Spring, Bethesda, MD, USA. 2. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Abstract
AIMS: Adolescents with Type 2 diabetes are more likely to have cardiovascular disease (CVD) risk factors but there are few data available among adolescents with prediabetes. We characterized CVD risk factors among adolescents with prediabetes in the USA and compared levels of those risk factors with adolescents with normal glucose. METHODS: The 2005-2014 National Health and Nutrition Examination Survey, a nationally representative cross-sectional survey, included 2843 adolescents aged 12-19 years after excluding those with diabetes. Prediabetes was based on an HbA1c , a fasting plasma glucose or a 2-h plasma glucose. We determined cardiometabolic risk factors in adolescents using age-appropriate cut-off points. We calculated odds ratios (OR) and 95% confidence intervals (CI) of these outcomes associated with having prediabetes compared with normal glucose levels. RESULTS: The weighted prevalence of prediabetes was 17.4%. After adjustment, prediabetes (vs. normal glucose) was associated with obesity (OR 1.86, 95% CI 1.35-2.55), low HDL-cholesterol (OR 1.62, 95% CI 1.08-2.44), high triglycerides (OR 1.61, 95% CI 1.12-2.30) and elevated liver transaminase (OR 2.09, 95% CI 1.19-3.67), but not with hypertension (OR 1.77, 95% CI 0.88-3.54), elevated total cholesterol (OR 1.30, 95% CI 0.82-2.06), elevated LDL-cholesterol (OR 1.59, 95% CI 0.88-2.88) or albuminuria (OR 1.24, 95% CI 0.76-2.02). CONCLUSIONS: US adolescents with prediabetes are more likely to have obesity, low HDL-cholesterol, high triglycerides and elevated liver transaminase than adolescents with normal glucose. Addressing prediabetes in youth is important for the prevention of Type 2 diabetes and long-term comorbidity. Published 2018. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
AIMS: Adolescents with Type 2 diabetes are more likely to have cardiovascular disease (CVD) risk factors but there are few data available among adolescents with prediabetes. We characterized CVD risk factors among adolescents with prediabetes in the USA and compared levels of those risk factors with adolescents with normal glucose. METHODS: The 2005-2014 National Health and Nutrition Examination Survey, a nationally representative cross-sectional survey, included 2843 adolescents aged 12-19 years after excluding those with diabetes. Prediabetes was based on an HbA1c , a fasting plasma glucose or a 2-h plasma glucose. We determined cardiometabolic risk factors in adolescents using age-appropriate cut-off points. We calculated odds ratios (OR) and 95% confidence intervals (CI) of these outcomes associated with having prediabetes compared with normal glucose levels. RESULTS: The weighted prevalence of prediabetes was 17.4%. After adjustment, prediabetes (vs. normal glucose) was associated with obesity (OR 1.86, 95% CI 1.35-2.55), low HDL-cholesterol (OR 1.62, 95% CI 1.08-2.44), high triglycerides (OR 1.61, 95% CI 1.12-2.30) and elevated liver transaminase (OR 2.09, 95% CI 1.19-3.67), but not with hypertension (OR 1.77, 95% CI 0.88-3.54), elevated total cholesterol (OR 1.30, 95% CI 0.82-2.06), elevated LDL-cholesterol (OR 1.59, 95% CI 0.88-2.88) or albuminuria (OR 1.24, 95% CI 0.76-2.02). CONCLUSIONS: US adolescents with prediabetes are more likely to have obesity, low HDL-cholesterol, high triglycerides and elevated liver transaminase than adolescents with normal glucose. Addressing prediabetes in youth is important for the prevention of Type 2 diabetes and long-term comorbidity. Published 2018. This article has been contributed to by US Government employees and their work is in the public domain in the USA.
Authors: Ann K Kershnar; Stephen R Daniels; Giuseppina Imperatore; Shana L Palla; Diana B Petitti; David J Pettitt; Santica Marcovina; Lawrence M Dolan; Richard F Hamman; Angela D Liese; Catherine Pihoker; Beatriz L Rodriguez Journal: J Pediatr Date: 2006-09 Impact factor: 4.406
Authors: Kimberly P Newton; Jiayi Hou; Nancy A Crimmins; Joel E Lavine; Sarah E Barlow; Stavra A Xanthakos; Jonathan Africa; Cynthia Behling; Michele Donithan; Jeanne M Clark; Jeffrey B Schwimmer Journal: JAMA Pediatr Date: 2016-10-03 Impact factor: 16.193
Authors: Kai McKeever Bullard; Sharon H Saydah; Giuseppina Imperatore; Catherine C Cowie; Edward W Gregg; Linda S Geiss; Yiling J Cheng; Deborah B Rolka; Desmond E Williams; Carl J Caspersen Journal: Diabetes Care Date: 2013-04-19 Impact factor: 19.112
Authors: Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin Journal: Pediatr Diabetes Date: 2021-12-26 Impact factor: 4.866
Authors: Linda J Andes; Yiling J Cheng; Deborah B Rolka; Edward W Gregg; Giuseppina Imperatore Journal: JAMA Pediatr Date: 2020-02-03 Impact factor: 16.193
Authors: P Di Bonito; M R Licenziati; D Corica; M G Wasniewska; A Di Sessa; E Miraglia Del Giudice; A Morandi; C Maffeis; M F Faienza; E Mozzillo; V Calcaterra; F Franco; G Maltoni; G Valerio Journal: J Endocrinol Invest Date: 2022-05-17 Impact factor: 5.467